Anti-diabetic

Category	Example	Example	Example	Example
Type 2	Empagliflozin and linagliptin	Empagliflozin and metformin hydrochloride	Glibenclamide	Glimepiride

Latest

The world’s most vulnerable suffer at the hands of global shipping issues

At the close of 2021 we experienced significant challenges in shipping medicines to the world’s most vulnerable, as global container and HGV driver shortages, crippled the sector. This, coupled with escalating costs due to increased demand and fuel price hikes, means that those most in need are suffering the life-threatening fallout. As we head into a new year, this doesn't look set to change.
An interview with EHP carrier Olatunji Olaleye

Olatunji recently led a team of health professionals to communities in Nigeria with one of IHP’s Essential Health Packs (EHPs). We spoke to him about the health situation in his home country and why donated medicines can play a positive part in strengthening health systems there.
A look back at 2021

As we draw to the end of what has been another challenging yet remarkable year for International Health Partners, we reflect on all that we’ve been able to do together to improve access to medicine for some of the world’s most vulnerable people.
After COVID-19, what's next for CSR?

Today, many companies see CSR as an essential self-regulating mechanism through which to ensure compliance with legal and ethical standards and make positive impacts on environment and society. Here, we take a look at the trends we're seeing in the sector and how IHP's new ESG matrix will support companies to reach their goals.